These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23763979)

  • 1. D-dimer: a biomarker for antihistamine-resistant chronic urticaria.
    Asero R
    J Allergy Clin Immunol; 2013 Oct; 132(4):983-6. PubMed ID: 23763979
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab.
    Asero R
    Clin Exp Dermatol; 2017 Aug; 42(6):667-669. PubMed ID: 28691309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria.
    Cugno M; Genovese G; Ferrucci S; Casazza G; Asero R; Marzano AV
    Br J Dermatol; 2018 Sep; 179(3):776-777. PubMed ID: 29582427
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.
    Takahagi S; Mihara S; Iwamoto K; Morioke S; Okabe T; Kameyoshi Y; Hide M
    Allergy; 2010 May; 65(5):649-56. PubMed ID: 19845571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
    Asero R; Tedeschi A; Cugno M
    Int Arch Allergy Immunol; 2010; 152(4):384-9. PubMed ID: 20203527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four cases of acute infectious urticaria showing significant elevation of plasma D-dimer level.
    Takahashi T; Minami S; Teramura K; Tanaka T; Fujimoto N
    J Dermatol; 2018 Aug; 45(8):1013-1016. PubMed ID: 29797525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
    Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
    Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adults.
    Gómez-Vera J; Gutiérrez-Ávila SA; Acosta-Gutiérrez DN; López-Tiro JJ; Bedolla-Barajas M
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):204-6. PubMed ID: 27369651
    [No Abstract]   [Full Text] [Related]  

  • 9. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria.
    Asero R; Marzano AV; Ferrucci S; Cugno M
    Int Arch Allergy Immunol; 2017; 172(1):40-44. PubMed ID: 28219067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy.
    Krause K; Ardelean E; Kessler B; Magerl M; Metz M; Siebenhaar F; Weller K; Worm M; Zuberbier T; Maurer M
    Allergy; 2010 Nov; 65(11):1494-5. PubMed ID: 20560911
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.
    Demitsu T; Yoneda K; Kakurai M; Sasaki K; Hiratsuka Y; Azuma R; Yamada T; Umemoto N
    J Dermatol; 2010 Sep; 37(9):827-9. PubMed ID: 20883370
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis.
    Asero R; Tedeschi A
    J Investig Allergol Clin Immunol; 2010; 20(5):386-90. PubMed ID: 20945604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE.
    Baek YS; Jeon J; Kim JH; Oh CH
    Clin Exp Dermatol; 2014 Oct; 39(7):795-800. PubMed ID: 25196271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
    Güzelbey O; Ardelean E; Magerl M; Zuberbier T; Maurer M; Metz M
    Allergy; 2008 Nov; 63(11):1563-5. PubMed ID: 18925897
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria.
    Magen E; Mishal J
    Clin Exp Dermatol; 2013 Jan; 38(1):7-12. PubMed ID: 23083221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
    Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
    Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of atorvastatin and antihistamines in comparison with antihistamines plus placebo in the treatment of chronic idiopathic urticaria: a controlled clinical trial.
    Pezeshkpoor F; Farid Hosseini R; Rafatpanah H; Shakerian B; Jabbari F; Zandkarimi MR; Yousefzadeh H; Sadri H; Bahrami A; Zamani MA
    Iran J Allergy Asthma Immunol; 2012 Sep; 11(3):236-40. PubMed ID: 22947909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU.
    Asero R; Marzano AV; Ferrucci S; Cugno M
    J Allergy Clin Immunol Pract; 2017; 5(6):1740-1742. PubMed ID: 28866106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.